Search for: "LILLI JOHNSON"
Results 121 - 140
of 242
Sort by Relevance
|
Sort by Date
22 Sep 2011, 3:39 am
” The story reports on payments by Eli Lilly and Co., down 46 percent since 2009; GlaxoSmithKline down 29 percent. [read post]
20 Sep 2011, 3:52 am
" The story reports on payments by Eli Lilly and Co., down 46 percent since 2009; GlaxoSmithKline down 29 percent. [read post]
8 Aug 2011, 12:53 pm
A South Carolina judge has ordered a Johnson & Johnson subsidiary to pay $327 million in fines for deceptive marketing of their anti-psychotic drug, Risperdal. [read post]
3 Aug 2011, 3:31 am
: Cour d’Appel Paris decision in Teva v Eli Lilly (Kluwer Patent Blog) US: CAFC confirms that isolated DNA may be patented: Association for Molecular Pathology v. [read post]
21 Jul 2011, 1:17 pm
The drug is being developed by Bristol-Myers Squibb and AstraZeneca, and other major manufacturers such as Johnson & Johnson and Eli Lilly are pursing similar drugs. [read post]
14 Jul 2011, 2:00 am
(Eli Lilly & Co. case). [read post]
14 Jul 2011, 2:00 am
(Eli Lilly & Co. case). [read post]
13 Jun 2011, 9:08 am
The three most commonly prescribed atypical antipsychotic drugs are listed in the article as Astra Zeneca's Seroquel, Johnson & Johnson's Risperdal, and Ely Lilly's Zyprexa. [read post]
13 Jun 2011, 7:54 am
., Eli Lilly & Co., Johnson & Johnson, and Pfizer Inc. were among the companies that supported Roche. [read post]
10 Jun 2011, 4:09 pm
Cir. 1997) (hereinafter, Eli Lilly). [read post]
7 Jun 2011, 11:06 am
Johnson & Johnson, Inc., 679 F. [read post]
2 Jun 2011, 12:46 pm
., 738 P.2d 1210, 1227-28 (Kan. 1987) (applied to medical device); Johnson v. [read post]
25 May 2011, 8:52 pm
From the pharmaceutical industry, amicus briefs were filed by Apotex; Sanofi-Aventis; Eli Lilly & Co.; BIO; Eisai; Johnson & Johnson; PhRMA; Teva; and GPhA. [read post]
19 May 2011, 10:24 am
Eli Lilly pleaded guilty to criminal charges for illegally marketing its drug Zyprexa, Pfizer settled a claim that its anti-psychotic drugs were improperly promoted for off label uses, and federal prosecution is pending against Johnson & Johnson for allegedly paying kickbacks to nursing homes to increase Risperdal prescriptions for dementia patients. [read post]
19 May 2011, 10:24 am
Eli Lilly pleaded guilty to criminal charges for illegally marketing its drug Zyprexa, Pfizer settled a claim that its anti-psychotic drugs were improperly promoted for off label uses, and federal prosecution is pending against Johnson & Johnson for allegedly paying kickbacks to nursing homes to increase Risperdal prescriptions for dementia patients. [read post]
19 May 2011, 10:24 am
Eli Lilly pleaded guilty to criminal charges for illegally marketing its drug Zyprexa, Pfizer settled a claim that its anti-psychotic drugs were improperly promoted for off label uses, and federal prosecution is pending against Johnson & Johnson for allegedly paying kickbacks to nursing homes to increase Risperdal prescriptions for dementia patients. [read post]
12 May 2011, 2:25 pm
Turns out, federal prosecutors are seeking roughly $1 billion to resolve a long-running probe into Johnson & Johnson’s marketing of the antipsychotic drug Riseprdal. [read post]
6 May 2011, 8:37 am
Johnson & Johnson, previously included in the group of companies under investigation, resolved an FCPA enforcement action last month and Koehler thinks their enforcement action provides a glimpse into potential future FCPA enforcement actions involving the pharmaceutical/medical device industry. [read post]
5 May 2011, 1:57 am
Last week, Eli Lilly. disclosed that it is in “advanced discussions” to settle bribery related allegations. [read post]
2 May 2011, 4:30 am
., a Johnson & Johnson subsidiary, should pay the state for what the jury found to be deceptive marketing by the company of its antipsychotic drug Risperdal. [read post]
